SYNGENE INTERNATIONAL LIMITED

Press Releases Syngene International Limited

Equities

SYNGENE

INE398R01022

Market Closed - NSE India S.E. Other stock markets 07:43:56 2024-07-04 EDT			5-day change	1st Jan Change
725.8 ^INR	+1.06%		+1.78%	+3.46%

07-02	Syngene International Limited Proposes Final Dividend for the Financial Year Ended March 31, 2024	CI
06-20	Syngene International Limited Receives an Intimation from the Superintendent of Central Tax, Bangalore South Commissionerate, Bangalore	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%, Biosimilars Up 114%, Research Services Up 31%	23-05-24	AQ
Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%, Biosimilars Up 54%, Research Services Up 23%, Generics Up 18%	23-02-15	AQ
Syngene International : Analysts/Institutional Investor Meet/Con. Call Updates	22-12-28	PU
Syngene International : Artelo Biosciences Enters Into Global R&D Partnership With Syngene International And Aptus Clinical For The Clinical Development Of ART27.13 In Oncology	18-06-12	PR
Syngene International : Commissions Dedicated R&D Center for Amgen	16-09-06	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer